NASDAQ:TORC
Delisted

Restorbio Stock News

etoro logo Buy TORC
*Your capital is at risk
$12.41
+0 (+0%)
At Close: Aug 17, 2022
NEW YORK, NY / ACCESSWIRE / May 11, 2020 / Juan Monteverde , founder and managing partner at Monteverde & Associates PC , a national securities firm headquartered at the Empire State Building in New Y
NEW YORK, NY / ACCESSWIRE / May 9, 2020 / Halper Sadeh LLP, a global investor rights law firm, continues to investigate whether the following proposed mergers are fair to shareholders. Halper Sadeh LL
Stocks Analysis by Zacks Investment Research covering: SPDR S&P 500, Amazon.com Inc, Netflix Inc, Uber Technologies Inc. Read Zacks Investment Research's latest article on Investing.com
The gaming simulators market size has the potential to grow by USD 7.21 billion during 2020-2024
Remdesivir, the investigational Gilead Sciences antiviral drug, looks more likely than ever to become the first treatment authorized by the FDA to treat
NEW YORK, April 30, 2020 -- CenterState Bank Corporation (CSFL) Lifshitz Law Firm, P.C. announces investigation into possible breach of fiduciary duties in connection with.
Adicet Bio, a privately held preclinical biotech looking to move ahead its “off-the-shelf” CAR-T cell therapies, has struck a deal with struggling
Good news from Gilead Sciences and a statement from the Federal Reserve offset some grim economic numbers

GOOGL, CHK among premarket gainers

01:21pm, Wednesday, 29'th Apr 2020
Spark Networks SE (NYSEMKT:LOV) +38% on 2H results.Chimerix (NASDAQ:CMRX) +29% on launch of DSTAT study in COVID-19.resTORbio (NASDAQ:TORC) +24% on merger with Adicet BioR. R. Donnelley & Sons (NY
Here's a roundup of top developments in the biotech space over the last 24 hours:Scaling The Peaks (Biotech stocks that hit 52-week highs April 28.) * AstraZeneca plc (NYSE: AZN) * Arcturus Therapeu
Technically speaking, the S&P 500’s jagged April recovery attempt remains in play amid still receding market volatility, writes Michael Ashbaugh.
Goldman Sachs Group Inc. raised its position in shares of resTORbio, Inc. (NASDAQ:TORC) by 46.4% in the fourth quarter, according to the company in its most recent disclosure with the Securities & Exc
Zacks Investment Research upgraded shares of resTORbio (NASDAQ:TORC) from a hold rating to a buy rating in a report released on Wednesday morning, Zacks.com reports. They currently have $1.25 price ob
Aytu BioScience (NASDAQ:AYTU) has begun shipping its rapid antibody blood test for COVID-19. Shares up 8% premarket.Stryker (NYSE:SYK) has developed a low-cost limited-release emergency response bed
Click to get the best stock tips daily for free!

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE